Ignite Creation Date:
2025-12-24 @ 12:11 PM
Ignite Modification Date:
2025-12-27 @ 10:39 PM
Study NCT ID:
NCT01708161
Status:
TERMINATED
Last Update Posted:
2018-09-13
First Post:
2012-09-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-19
First Submit QC Date:
None
Study First Post Date:
2012-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-31
Results First Submit QC Date:
None
Results First Post Date:
2018-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-15
Last Update Post Date:
2018-09-13
Last Update Post Date Type:
ACTUAL